GCG and Hyperglycemia: For example, GLP-1(9–36) is reported to promote dose-dependent vascular relaxation ex vivo and to inhibit hyperglycaemia-induced mitochondrial reactive oxygen species (ROS) generation both in vitro and in vivo [4, 5, 21, 22].